This inventor holds 4 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Chemical & Biopharmaceutical Laboratories of Patras Sa, Chemical & Biopharmaceutical Laboratories of Patra, Chemical & Biopharmaceuticals Laboratories of Patras S.a.. Active years: 2019-2025.
Company Filing History:
2 out of 5 
1 out of 1 
1 out of 1 Years Active: 2019-2025
Title: Innovations of Dimitrios Gatos
Introduction
Dimitrios Gatos is a notable inventor based in Patras, Greece. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of peptide modifier compounds. With a total of 4 patents to his name, Gatos continues to push the boundaries of innovation in his area of expertise.
Latest Patents
One of Gatos's latest patents focuses on amino diacids containing peptide modifiers. The invention relates to peptide modifier compounds of Formula (1), or a salt thereof, wherein: a is an integer from 1 to 10, more preferably from 1 to 3; b is an integer from 0 to 7; Z is a terminal group and Y is a bivalent group. Further aspects of the invention relate to intermediates in the preparation of compounds of Formula (1), and the use of these compounds in the synthesis of peptide derivatives.
Career Highlights
Throughout his career, Dimitrios Gatos has worked with reputable organizations such as Chemical & Biopharmaceutical Laboratories of Patras S.A. and Chemical & Biopharmaceutical Laboratories of Patra. His work in these institutions has allowed him to develop and refine his innovative ideas in the biopharmaceutical sector.
Collaborations
Gatos has collaborated with several professionals in his field, including Kleomenis Barlos and Kostas Barlos. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Dimitrios Gatos is a prominent figure in the realm of biopharmaceutical innovations. His work on peptide modifiers and collaborations with industry professionals highlight his commitment to advancing scientific knowledge and technology.